Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Introduction: Acute kidney injury (AKI) is a frequent complication of cardiopulmonary bypass (CPB). The lack of early biomarkers has impaired our ability to intervene in a timely manner. We previously showed in a small cohort of patients that plasma neutrophil gelatinase-associated lipocalin (NGAL), measured using a research enzyme-linked immunosorbent assay, is an early predictive biomarker of AKI after CPB. In this study we tested whether a point-of-care NGAL device can predict AKI after CPB in a larger cohort. Methods: First, in a cross-sectional pilot study including 40 plasma samples (NGAL range 60 to 730 ng/ml) and 12 calibration standards (NGAL range 0 to 1,925 ng/ml), NGAL measurements by enzyme-linked immunosorbent assay and by Triage® NGAL Device (Biosite Inc., San Diego, CA, USA) were highly correlated (r = 0.94). Second, in a subsequent prospective uncontrolled cohort study, 120 children undergoing CPB were enrolled. Plasma was collected at baseline and at frequent intervals for 24 hours after CPB, and analyzed for NGAL using the Triage® NGAL device. The primary outcome was AKI, which was defined as a 50% or greater increase in serum creatinine. Results: AKI developed in 45 patients (37%), but the diagnosis using serum creatinine was delayed by 2 to 3 days after CPB. In contrast, mean plasma NGAL levels increased threefold within 2 hours of CPB and remained significantly elevated for the duration of the study. By multivariate analysis, plasma NGAL at 2 hours after CPB was the most powerful independent predictor of AKI (β = 0.004, P < 0.0001). For the 2-hour plasma NGAL measurement, the area under the curve was 0.96, sensitivity was 0.84, and specificity was 0.94 for prediction of AKI using a cut-off value of 150 ng/ml. The 2 hour postoperative plasma NGAL levels strongly correlated with change in creatinine (r = 0.46, P < 0.001), duration of AKI (r = 0.57, P < 0.001), and length of hospital stay (r = 0.44, P < 0.001). The 12-hour plasma NGAL strongly correlated with mortality (r = 0.48, P = 0.004) and all measures of morbidity mentioned above. Conclusion: Accurate measurements of plasma NGAL are obtained using the point-of-care Triage® NGAL device. Plasma NGAL is an early predictive biomarker of AKI, morbidity, and mortality after pediatric CPB.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The finding that NGAL was one of the most highly expressed proteins following ischaemia-reperfusion injury in kidney cells [372-374], and prognostic of kidney damage long before the more traditional marker creatinine was raised significantly, has led to considerable interest in this protein, especially as a marker of renal injury [375-389]”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bellomo, R., Ronco, C., Kellum, J. A., Mehta, R. L., Palevsky, P., & workgroup, T. A. (2004) · Critical Care · doi:10.1186/cc2872 · Cited by 6,781
Mishra, J., Dent, C., Tarabishi, R., Mitsnefes, M. M., Ma, Q., Kelly, C., Ruff, S. M., Zahedi, K., Shao, M., Bean, J., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)74811-x · Cited by 2,394 · cited 5×
“A major reason for the failure to find an effective treatment in patients is the paucity of early biomarkers for AKI, akin to troponins in acute myocardial disease, and hence a delay in initiating therapy [ 16 ].”
InfluentialSelf-citationMishra, J., Ma, Q., Prada, A., Mitsnefes, M., Zahedi, K., Yang, J., Barasch, J., & Devarajan, P. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000088027.54400.c6 · Cited by 1,749
Self-citationLassnigg, A., Schmidlin, D., Mouhieddine, M., Bachmann, L. M., Druml, W., Bauer, P., & Hiesmayr, M. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000130340.93930.dd · Cited by 1,348 · cited 1×
“minor degrees of postoperative AKI, as manifest by only a 0.2 to 0.3 mg/dl rise in serum creatinine from baseline, predict a significant increase in short-term mortality [ 5 ,6].”
BackgroundInfluentialIndependent Association between Acute Renal Failure and Mortality following Cardiac Surgery
Chertow, G. M., Levy, E. M., Hammermeister, K. E., Grover, F., & Daley, J. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00058-8 · Cited by 1,177 · cited 1×
“9 [4].”
Mangano, C. M., Diamondstone, L. S., Ramsay, J. G., Aggarwal, A., Herskowitz, A., & Mangano, D. T. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-3-199802010-00005 · Cited by 1,086
A Clinical Score to Predict Acute Renal Failure after Cardiac Surgery
Thakar, C. V., Arrigain, S., Worley, S., Yared, J.-P., & Paganini, E. P. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004040331 · Cited by 1,067 · cited 1×
“Clinical investigations have identified several risk factors associated with the development of AKI after CPB, the majority related to either impaired renal perfusion or decreased renal reserve, and have resulted in the development of clinical scoring systems for the prediction of AKI [10-13].”
BackgroundAcute Kidney Injury Associated with Cardiac Surgery
Rosner, M. H., & Okusa, M. D. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00240605 · Cited by 1,063 · cited 1×
“Acute kidney injury (AKI), previously referred to as acute renal failure, is a frequent and serious complication encountered in 30% to 50% of subjects after CPB [2,3].”
BackgroundUpdate on Mechanisms of Ischemic Acute Kidney Injury
Devarajan, P. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006010017 · Cited by 1,026 · cited 1×
“sciences have illuminated the pathogenesis of AKI and have paved the way to successful therapeutic approaches in animal models [14].”
BackgroundSelf-citationMori, K., Lee, H. T., Rapoport, D., Drexler, I. R., Foster, K., Yang, J., Schmidt-Ott, K. M., Chen, X., Li, J. Y., Weiss, S., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23056 · Cited by 954
Self-citation
Cited by
Items 101–200 of 488
Zdziechowska, M., Gluba-Brzózka, A., Poliwczak, A. R., Franczyk, B., Kidawa, M., Zielińska, M., & Rysz, J. (2020) · International Urology and Nephrology · doi:10.1007/s11255-020-02530-x · Cited by 89
Influence of Thyroid Function on Different Kidney Function Tests
Kimmel, M., Braun, N., & Alscher, M. D. (2011) · Kidney & Blood Pressure Research · doi:10.1159/000329354 · Cited by 85
Biomarkers of delayed graft function as a form of acute kidney injury in kidney transplantation
Małyszko, J., Łukaszyk, E., Głowińska, I., & Durlik, M. (2015) · Scientific Reports · doi:10.1038/srep11684 · Cited by 77
Plasma NGAL for the Diagnosis of AKI in Patients Admitted from the Emergency Department Setting
Soto, K., Papoila, A. L., Coelho, S., BENNETT, M. R., Ma, Q., Rodrigues, B., Fidalgo, P., Frade, F., & Devarajan, P. (2013) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.12181212 · Cited by 80
“Discussion The majority of studies on pNGAL has been performed in well controlled settings of hospital-acquired AKI, such as cardiac surgery (10,18,36), contrast administration (37), or critically ill patients (11,13–16).”
BackgroundMethodSelf-citationNeurophil gelatinase-associated lipocalin as a new biomarker in laboratory medicine
Makris, K., Rizos, D., Kafkas, N., & Haliassos, A. (2012) · Clinical Chemistry and Laboratory Medicine · doi:10.1515/cclm-2012-0227 · Cited by 75
The Japanese clinical practice guideline for acute kidney injury 2016
Doi, K., Nishida, O., Shigematsu, T., Sadahiro, T., Itami, N., Iseki, K., Yuzawa, Y., Okada, H., Koya, D., Kiyomoto, H., et al. (2018) · Clinical and Experimental Nephrology · doi:10.1007/s10157-018-1600-4 · Cited by 75
Screening for Kidney Diseases: Older Measures versus Novel Biomarkers
Wu, I. C.-Y., & Parikh, C. R. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02030408 · Cited by 72
“Plasma NGAL has also been used to predict morbidity and mortality in pediatric patients who undergo cardiac surgery (11).”
MethodEstrogen Is Renoprotective via a Nonreceptor-dependent Mechanism after Cardiac Arrest In Vivo
Hutchens, M. P., Nakano, T., Kosaka, Y., Dunlap, J. B., Zhang, W. H., Herson, P. S., Murphy, S. J., Anderson, S., & Hurn, P. D. (2010) · Anesthesiology · doi:10.1097/aln.0b013e3181c98da9 · Cited by 77
“including NGAL, which is elevated in the urine within 2 h after focal ischemia(31) and reliably predicts AKI after cardiac surgery.(34,35) We have demonstrated in this study that NGAL”
BackgroundNeutrophil gelatinase–associated lipocalin (NGAL) as a Biomarker for Early Acute Kidney Injury
Shemin, D. G., & Dworkin, L. D. (2011) · Critical Care Clinics · doi:10.1016/j.ccc.2010.12.003 · Cited by 70
Glassford, N. J., Schneider, A. G., Xu, S., Eastwood, G. M., Young, H., Peck, L., Venge, P., & Bellomo, R. (2013) · Intensive Care Medicine · doi:10.1007/s00134-013-3040-7 · Cited by 76
“Neutrophil Gelatinase-Associated Lipocalin/Human Neutrophil Lipocalin (NGAL/HNL) is a potentially useful biomarker for Acute Kidney Injury (AKI) [1-4], and proprietary assays are now available [5-9].”
BackgroundMethodNew Biomarkers of Acute Kidney Injury and the Cardio-renal Syndrome
Hawkins, R. C. (2011) · Annals of Laboratory Medicine · doi:10.3343/kjlm.2011.31.2.72 · Cited by 76
“[54-59], contrast procedures [60, 61], intensive care units [62-64] and the emergency department [65].”
BackgroundNeutrophil gelatinase-associated lipocalin
Haase, M., Bellomo, R., & Haase-Fielitz, A. (2010) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e328340063b · Cited by 46
Biomarkers of Acute Kidney Injury
Sirota, J. C., Klawitter, J., & Edelstein, C. L. (2011) · Journal of Toxicology · doi:10.1155/2011/328120 · Cited by 73
“In addition, the 2-hour postoperative NGAL levels correlated with duration of AKI and length of hospital stay, while the 12-hour NGAL level correlated strongly with mortality [17].”
BackgroundYamashita, T., Doi, K., Hamasaki, Y., Matsubara, T., Ishii, T., Yahagi, N., Nangaku, M., & Noiri, E. (2014) · Critical Care · doi:10.1186/s13054-014-0716-5 · Cited by 65
“Plasma NGAL was determined (Triage NGAL Device; Alere Medical, San Diego, CA, USA) as described previously [28].”
MethodNeutrophil gelatinase-associated lipocalin as a risk marker in cardiovascular disease
Sivalingam, Z., Larsen, S. B., Grove, E. L., Hvas, A., Kristensen, S. D., & Magnusson, N. E. (2017) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2017-0120 · Cited by 67
“Others found that plasma NGAL concentration tripled and remained significantly elevated in 120 children who developed AKI after cardiac surgery [48].”
BackgroundKatagiri, D., Doi, K., Matsubara, T., Negishi, K., Hamasaki, Y., Nakamura, K., Ishii, T., Yahagi, N., & Noiri, E. (2013) · Journal of Critical Care · doi:10.1016/j.jcrc.2013.01.009 · Cited by 63
Acute kidney injury biomarkers: renal angina and the need for a renal troponin I
Goldstein, S. L. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-135 · Cited by 68
“Subsequently, multiple studies have confirmed the predictive ability of NGAL in the pediatric CPB setting [29-31].”
BackgroundBiomarkers of Acute Kidney Injury in Different Clinical Settings: A Time to Change the Paradigm?
Małyszko, J. (2010) · Kidney & Blood Pressure Research · doi:10.1159/000319505 · Cited by 60
Cai, L., Borowiec, J. W., Xu, S., Han, W., & Venge, P. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.01.030 · Cited by 60
Kidney Injury Molecule-1 and Cardiovascular Diseases: From Basic Science to Clinical Practice
Medić, B., Rovčanin, B., Jovanović, G. B., Radojevic-Skodric, S. M., & Prostran, M. S. (2015) · BioMed Research International · doi:10.1155/2015/854070 · Cited by 62
Cardiac Biomarkers and Acute Kidney Injury After Cardiac Surgery
Bucholz, E. M., Whitlock, R. P., Zappitelli, M., Devarajan, P., Eikelboom, J. W., Garg, A. X., Thiessen‐Philbrook, H., Devereaux, P. J., Krawczeski, C. D., Kavsak, P. A., et al. (2015) · PEDIATRICS · doi:10.1542/peds.2014-2949 · Cited by 59
“92 Septal defect repair 14 (28) 9 (28) 6 (26) Inflow/outflow tract or valve procedure 15 (29) 10 (31) 5 (22) Combined procedure 22 (43) 13 (41) 12 (52) RACHS-1 score, n (%) .”
Self-citationAxelrod, D. M., Anglemyer, A. T., Sherman-Levine, S., Zhu, A., Grimm, P. C., Roth, S. J., & Sutherland, S. M. (2013) · Pediatric Critical Care Medicine · doi:10.1097/01.pcc.0000436473.12082.2f · Cited by 61
“AKI in children undergoing corrective cardiac surgery has been independently associated with longer length of stay, a greater need for mechanical ventilation, and higher hospital mortality rates (2, 4).”
BackgroundThe potential use of biomarkers in predicting contrast-induced acute kidney injury
Andreucci, M., Faga, T., Riccio, E., Sabbatini, M., Pisani, A., & Michael, A. (2016) · International Journal of Nephrology and Renovascular Disease · doi:10.2147/ijnrd.s105124 · Cited by 59
Neutrophil Gelatinase–Associated Lipocalin in Dogs with Naturally Occurring Renal Diseases
Hsu, W., Lin, Y.-S., Hu, Y., Wong, M.-L., Lin, F.-Y., & Lee, Y. (2014) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.12288 · Cited by 57
The Japanese Clinical Practice Guideline for acute kidney injury 2016
Doi, K., Nishida, O., Shigematsu, T., Sadahiro, T., Itami, N., Iseki, K., Yuzawa, Y., Okada, H., Koya, D., Kiyomoto, H., et al. (2018) · Journal of Intensive Care · doi:10.1186/s40560-018-0308-6 · Cited by 64
“With regard to the survival outcomes, two studies have reported that NGAL is significantly associated with mortality [338, 339].”
Lamb, E. J., & Price, C. P. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6164-9.00025-1 · Cited by 67
Impact of gestational age, sex, and postnatal age on urine biomarkers in premature neonates
Saeidi, B., Koralkar, R., Griffin, R. L., Halloran, B., Ambalavanan, N., & Askenazi, D. J. (2015) · Pediatric Nephrology · doi:10.1007/s00467-015-3129-z · Cited by 56
“Several articles have investigated the use of urinary biomarkers as a predictive and diagnostic tool for AKI in different populations [15–20].”
Neutrophil gelatinase-associated lipocalin as a marker of acute renal disease
Haase, M., Haase-Fielitz, A., Bellomo, R., & Mertens, P. (2011) · Current opinion in hematology · doi:10.1097/moh.0b013e3283411517 · Cited by 56
Carter, J. L., Parker, C. T., Stevens, P. E., Eaglestone, G., Knight, S., Farmer, C. K. T., & Lamb, E. J. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2015.250993 · Cited by 51
Pediatric acute kidney injury: prevalence, impact and management challenges
Ciccia, E., & Devarajan, P. (2017) · International Journal of Nephrology and Renovascular Disease · doi:10.2147/ijnrd.s103785 · Cited by 54
“Initial single-center studies of cardiac surgical patients by Bennett et al 36 and Dent et al 37 identified the correlation of early NGAL measurements in the urine and plasma, respectively, with severity and duration of AKI, length of stay, dialysis requirement, and death.”
Self-citationFurosemide Response Predicts Acute Kidney Injury After Cardiac Surgery in Infants and Neonates
Borasino, S., Wall, K. M., Crawford, J. H., Hock, K. M., Cleveland, D. C., Rahman, F., Martin, K. D., & Alten, J. A. (2018) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000001478 · Cited by 54
“AKI biomarkers have shown promise for early identification of CS-AKI (13, 14), but they are not readily available for clinical use at this time.”
BackgroundReview article: Acute kidney injury in critical illness
Bagshaw, S. M., Bellomo, R., Devarajan, P., Johnson, C., Karvellas, C. J., Kutsogiannis, D. J., Mehta, R. L., Pannu, N., Romanovsky, A. S., Sheinfeld, G. R., et al. (2010) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-010-9375-4 · Cited by 64
Self-citationYang, H. N., Boo, C. S., Kim, M.-G., Jo, S.-K., Cho, W. Y., & Kim, H. K. (2010) · American Journal of Nephrology · doi:10.1159/000309841 · Cited by 53
Serum creatinine role in predicting outcome after cardiac surgery beyond acute kidney injury
Najafi, M. (2014) · World Journal of Cardiology · doi:10.4330/wjc.v6.i9.1006 · Cited by 53
Progression From Acute Kidney Injury to Chronic Kidney Disease: A Pediatric Perspective
Goldstein, S. L., & Devarajan, P. (2008) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2008.04.007 · Cited by 53
Self-citationYim, H., Yim, H., Bae, E., Woo, S.-U., & Yoo, K. (2014) · Pediatric nephrology (Berlin, West) · doi:10.1007/s00467-014-2845-0 · Cited by 46
Di Grande, A., Giuffrida, C., Carpinteri, G., Narbone, G., Pirrone, G., Di Mauro, A., Calandra, S., Noto, P., Moli, C. L., Alongi, B., et al. (2009) · PubMed · Cited by 52
Emerging Concepts in Acute Kidney Injury Following Cardiac Surgery
Hudson, C., Hudson, J. K. C., Swaminathan, M., Shaw, A., Stafford‐Smith, M., & Patel, U. D. (2008) · Seminars in Cardiothoracic and Vascular Anesthesia · doi:10.1177/1089253208328582 · Cited by 51
“Many of the positive trials reported in the literature arise from the pediatric CPB population, which is more homogeneous and, therefore, more predictable.(39,41,43,52,55) Perhaps the most important barrier to studying therapeutic agents for the treatment of AKI is the lack of consensus regarding what constitutes a me…”
BackgroundResultNew biomarkers for acute renal injury
Soni, S. S., Pophale, R., & Ronco, C. (2011) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2011.664 · Cited by 50
Srisawat, N., Praditpornsilpa, K., Patarakul, K., Techapornrung, M., Daraswang, T., Sukmark, T., Khositrangsikun, K., Fakthongyoo, A., Oranrigsupak, P., Praderm, L., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143367 · Cited by 49
Zhao, H., Pan, X.-D., Gong, Z., Zheng, J., Liu, Y., Zhu, J., & Sun, L. (2015) · PubMed Central · doi:10.3978/j.issn.2072-1439.2015.07.19 · Cited by 47
“In those biomarkers, promising results have been reported for neutrophil gelatinase-associated lipocalin (NGAL) and cystatin C (22-25).”
BackgroundKoca, U., Olguner, Ç. G., Ergür, B. U., Altekin, E., Taşdöğen, A., Duru, S., Girgin, A. P., Gündüz, K., Mıçılı, S. Ç., Güzeldağ, S., et al. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/292687 · Cited by 46
Biomarkers in Acute Kidney Injury
Edelstein, C. L. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803014-1.00006-6 · Cited by 47
Fadel, F. I., Rahman, A. M. O. A., Mohamed, M. F., Habib, S. A., Ibrahim, M. H., Sleem, Z., Bazaraa, H. M., & Soliman, M. M. (2012) · Archives of Medical Science · doi:10.5114/aoms.2012.28552 · Cited by 51
“On the other hand, plasma NGAL pumped up its level early when AKI developed, which is why it was gradually washed out of the blood stream [23].”
BackgroundWoo, K., Choi, J.-L., Kim, B., Kim, J.-E., An, W.-S., & Han, J. (2012) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2012.36.4.307 · Cited by 44
“A variety of clinical settings have been examined, including cardiac surgery, contrast administration, septic shock, intensive care units, the emergency department, and even renal transplantation [7,14-22].”
BackgroundLiebetrau, C., Gaede, L., Doerr, O., Blumenstein, J., Rixe, J., Teichert, O., Willmer, M., Weber, M. A., Rolf, A., Möllmann, H., et al. (2013) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2013.860615 · Cited by 41
Małyszko, J., Małyszko, J. S., & Myśliwiec, M. (2009) · Clinical Transplantation · doi:10.1111/j.1399-0012.2009.01034.x · Cited by 45
Acute kidney injury after heart transplant in young children: risk factors and outcomes
on behalf of the Western Canadian Complex Pediatric Therapies Follow-Up Group, MacDonald, C., Norris, C. M., Alton, G. Y., Urschel, S., Joffe, A. R., & Morgan, C. (2015) · Pediatric Nephrology · doi:10.1007/s00467-015-3252-x · Cited by 41
Filho, L. T., Grande, A. J., Colonetti, T., Della, É. S. P., & da Rosa, M. I. (2017) · Pediatric Nephrology · doi:10.1007/s00467-017-3704-6 · Cited by 41
Hall, P. S., Mitchell, E., Smith, A. F., Cairns, D. A., Messenger, M. P., Hutchinson, M., Wright, J. M., Vinall‐Collier, K. A., Corps, C., Hamilton, P., et al. (2018) · Health Technology Assessment · doi:10.3310/hta22320 · Cited by 44
Early detection of acute kidney injury after pediatric cardiac surgery
Jefferies, J. L., & Devarajan, P. (2016) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2016.01.011 · Cited by 41
“In addition, early NGAL measurements in the setting of pediatric CPB are strongly correlated with and predictive of graded AKI severity as well as AKI duration [67–70,76].”
BackgroundInfluentialSelf-citationBiomarkers and physiopathology in the cardiorenal syndrome
Bouquegneau, A., Krzesinski, J.-M., Delanaye, P., & Cavalier, E. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.10.041 · Cited by 40
“In a multicentre AKI biomarkers study, both urine and plasma NGAL were linearly associated with a composite outcome of in-hospital death or dialysis, and also with the length of hospital and intensive care unit stay (42).”
BackgroundCharacteristics of an Ideal Biomarker of Kidney Diseases
BENNETT, M. R., & Devarajan, P. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-375672-5.10001-5 · Cited by 54
Self-citationDoi, K., Urata, M., Katagiri, D., Inamori, M., Murata, S., Hisagi, M., Ōno, M., Matsubara, T., Ishii, T., Yahagi, N., et al. (2013) · Critical Care · doi:10.1186/cc13104 · Cited by 39
“Plasma NGAL, a new AKI biomarker, has demonstrated its clinical utility in studies of both pediatric and adult patients of post-cardiac surgery [12,15-19].”
BackgroundGist, K. M., Kaufman, J., da Cruz, E. M., Friesen, R. H., Crumback, S. L., Linders, M., Edelstein, C., Altmann, C. J., Palmer, C. E., Jalal, D. I., et al. (2016) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000000674 · Cited by 39
“Risk Adjustment for Congenital Heart Surgery-1 surgical complexity score > 3, n (%) 32 (34) 2 (17) 0.”
BackgroundPronschinske, K. B., Qiu, S., Wu, C. C. N., Kato, T., Khawaja, T., Takayama, H., Naka, Y., Templeton, D. L., George, I., FARR, M. A., et al. (2014) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2014.06.007 · Cited by 42
Kidher, E. S., Harling, L., Ashrafian, H., Naase, H., Chukwuemeka, A. O., Anderson, J., Francis, D. P., & Athanasiou, T. (2014) · Journal of Cardiothoracic Surgery · doi:10.1186/1749-8090-9-89 · Cited by 44
“This study aimed to examine the role of aortic stiffness and neutrophil gelatinase-associated lipocalin (NGAL) as predictors of AKI or need for early medical renal intervention following aortic valve replacement (AVR).”
BackgroundMethodInfluentialRalib, A. M., Nor, M. B. M., & Pickering, J. W. (2016) · Nephrology · doi:10.1111/nep.12796 · Cited by 38
“Plasma NGAL was analyzed using the Triage NGAL test (Biosite, San Diego, CA, USA).(20) Plasma creatinine was analysed using the Olympus AU2700 chemistryimmunoanalyzer (Olympus, Philadelphia, PA, USA).”
MethodBiomarkers in cardiorenal syndromes
Tan, K. M. L., & Sethi, S. K. (2014) · Translational research · doi:10.1016/j.trsl.2014.04.011 · Cited by 37
“94) for predicting AKI with a cutoff of 150 ng/mL in children undergoing cardiac surgery.(110) More recently, an automated commercial method using chemiluminescent microparticle immunoassay on the ARCHITECT platform (Abbott Diagnostics) was developed to measure urine NGAL.”
MethodRonco, C., Cruz, D., & Noland, B. (2012) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2011.11.015 · Cited by 40
Mohamed, F., Endre, Z. H., & Buckley, N. A. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12601 · Cited by 42
Diagnosis of cardiac surgery-associated acute kidney injury from functional to damage biomarkers
Vandenberghe, W., Loor, J. D., & Hoste, E. A. J. (2016) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000419 · Cited by 40
Metabolomics in the Developing Human Being
Syggelou, A., Iacovidou, N. M., Atzori, L., Xanthos, T. T., & Fanos, V. (2012) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2012.07.002 · Cited by 36
Progression of chronic kidney disease after acute kidney injury
Devarajan, P., & Jefferies, J. L. (2015) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2015.12.006 · Cited by 39
“Themost extensively studied novel AKI biomarker is NGAL, especially in the setting of pediatric cardiac surgery [92–98].”
BackgroundSelf-citationTorregrosa, I., Montoliu, C., Urios, A., Mlili, N. E., Puchades, M. J., Solís, M. A., Sanjuán, R., Blasco, M. L., Ramos, C., Tomás, P., et al. (2012) · PubMed · doi:10.3265/nefrologia.pre2011.sep.10988 · Cited by 35
Tweddell, S. M., Loomba, R. S., Cooper, D. S., & Benscoter, A. L. (2019) · Congenital Heart Disease · doi:10.1111/chd.12779 · Cited by 37
Evaluation of Renal Function, Water, Electrolytes, and Acid-Base Balance
Oh, M. S. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0974-2.00014-2 · Cited by 37
Algaze, C. A., Koth, A. M., Wise‐Faberowski, L., Hanley, F. L., Krawczeski, C. D., & Axelrod, D. M. (2016) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000000984 · Cited by 35
Volta, C. A., Trentini, A., Farabegoli, L., Manfrinato, M. C., Alvisi, V., Dallocchio, F., Marangoni, E., Alvisi, R., & Bellini, T. (2013) · Journal of Inflammation · doi:10.1186/1476-9255-10-29 · Cited by 36
“[29].”
Neutrophil Gelatinase Associated Lipocalin in Acute Kidney Injury
Peacock, W. F., Maisel, A. S., Kim, J., & Ronco, C. (2013) · Postgraduate Medicine · doi:10.3810/pgm.2013.11.2715 · Cited by 32
Role of neutrophil gelatinase-associated lipocalin for early detection of acute kidney injury
Kalra, O. P., Sanjeevani, S., Pruthi, S., Kalra, S., & Goel, A. (2014) · International Journal of Critical Illness and Injury Science · doi:10.4103/2229-5151.141420 · Cited by 32
“[33] found the 2‑hour postoperative pNGAL level a reliable predictor of duration of AKI and length of hospital stay, while the 12‑hour pNGAL level was a predictor of mortality.”
Cantinotti, M., Storti, S., Lorenzoni, V., Arcieri, L., Moschetti, R., Murzi, B., Spadoni, I., Passino, C., & Clerico, A. (2012) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2012-0125 · Cited by 32
Cavalier, E., Bekaert, A.-C., Carlisi, A., Legrand, D., Krzesinski, J.-M., & Delanaye, P. (2010) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2011.044 · Cited by 31
“Both tests have been correlated against an established and validated ELISA that uses mouse monoclonal antibody raised against human NGAL ( HYB211-05; AntibodyShop, Gentofte, Denmark) (5, 6).”
Methodde Geus, H. D., Woo, J. G., Wang, Y., Devarajan, P., Betjes, M., le Noble, J., & Bakker, J. (2011) · Nephron Extra · doi:10.1159/000330428 · Cited by 33
Self-citationUrinary NGAL-Positive Acute Kidney Injury and Poor Long-term Outcomes in Hospitalized Patients
Singer, E., Schrezenmeier, E. V., Elger, A., Seelow, E., Krannich, A., Luft, F. C., & Schmidt-Ott, K. M. (2016) · Kidney International Reports · doi:10.1016/j.ekir.2016.07.003 · Cited by 36
Proteomic analysis of acute kidney injury: Biomarkers to mechanisms
BENNETT, M. R., & Devarajan, P. (2010) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201000066 · Cited by 33
“The deployment of standardized clinical platforms for the rapid and accurate measurement of NGAL in urine [79] and plasma [80] will facilitate the widespread use and validation of NGAL as an AKI biomarker.”
MethodSelf-citationSevere protein C deficiency is associated with organ dysfunction in patients with severe sepsis
Shaw, A., Vail, G. M., Haney, D. J., Xie, J., & Williams, M. D. (2011) · Journal of Critical Care · doi:10.1016/j.jcrc.2011.05.006 · Cited by 33
Pediatric Acute Kidney Injury: Different From Acute Renal Failure, But How And Why?
Devarajan, P. (2012) · Current Pediatrics Reports · doi:10.1007/s40124-012-0003-3 · Cited by 31
Self-citationNeutrophil Gelatinase-Associated Lipocalin in Acute Kidney Injury
Makris, K., & Kafkas, N. V. (2012) · Advances in clinical chemistry · doi:10.1016/b978-0-12-394383-5.00012-6 · Cited by 36
Bojan, M., Vicca, S., Lopez-Lopez, V., Mogenet, A., Pouard, P., Falissard, B., & Journois, D. (2013) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04730513 · Cited by 30
“Our findings are consistent with previous reports, showing a peak of uNGAL at 2 hours after CPB in children (1,8,10,12,13,33).”
ResultTowards a biomarker panel for the assessment of AKI in children receiving intensive care
McCaffrey, J., Coupes, B. M., Chaloner, C., Webb, N. J. A., Barber, R., & Lennon, R. (2015) · Pediatric Nephrology · doi:10.1007/s00467-015-3089-3 · Cited by 30
“These include human neutrophil gelatinaseassociated lipocalin (NGAL) [9–12], cystatin-C (Cys-C) [13, 14] and kidney injury molecule-1 (KIM-1) [12, 15].”
BackgroundWang, H., He, X., Ma, Y., Jiang, X., Xia, Y., Ye, Z., Zhao, Z., & Tao, H. (2010) · The Anatomical Record · doi:10.1002/ar.21230 · Cited by 32
“Serum NGAL level has been shown to be elevated early in acute renal injury (Mishra et al., 2005; Dent et al., 2007) and ovarian borderline cancer (Lim et al., 2007).”
BackgroundThe Future of Pediatric Acute Kidney Injury Management—Biomarkers
Devarajan, P. (2008) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2008.05.010 · Cited by 29
Self-citationMałyszko, J., Bachórzewska-Gajewska, H., Małyszko, J. S., Iaina-Levin, N., Kobus, G., & Dobrzycki, S. (2011) · Archives of Medical Science · doi:10.5114/aoms.2011.24136 · Cited by 29
Fuhrman, D. Y., Stanski, N. L., Krawczeski, C. D., Greenberg, J. H., Akcan‐Arikan, A., Basu, R. K., Goldstein, S. L., Gist, K. M., workgroup, T. A. 2., Alobaidi, R., et al. (2023) · Pediatric Nephrology · doi:10.1007/s00467-023-06133-3 · Cited by 29
“Unfortunately, despite good to excellent performance in multiple studies [40–42], most structural biomarkers are not routinely used clinically due to lack of biomarker assay availability or regulatory approval, or because of cost.”
BackgroundSelf-citationAcute Kidney Injury in Children: Prevention, Treatment and Rehabilitation
Goldstein, S. L. (2011) · Contributions to nephrology · doi:10.1159/000329394 · Cited by 29
Laboratory parameters of cardiac and kidney dysfunction in cardio-renal syndromes
Cruz, D. N., Goh, C. Y., Palazzuoli, A., Slavin, L., Calabrò, A., Ronco, C., & Maisel, A. S. (2011) · Heart Failure Reviews · doi:10.1007/s10741-011-9231-9 · Cited by 29
“It can be measured in blood as a point-of-care test [9] and in the urine using a standardized laboratory platform [10].”
Jacobsen, S. E., Berg, L. C., Tvermose, E., Laurberg, M., & van Galen, G. (2018) · Veterinary Clinical Pathology · doi:10.1111/vcp.12670 · Cited by 27
Shavit, L., Dolgoker, I., Ivgi, H., Assous, M. V., & Slotki, I. N. (2011) · Kidney & Blood Pressure Research · doi:10.1159/000323897 · Cited by 28
“In our patients, 80p of AKI patients were diabetic and diabetes increased the risk for AKI 7.4-fold and the risk for postoperative infection and death 6.9-fold compared to nondiabetic patients. We also established a significant correlation between baseline serum NGAL and DM.Our results demonstrate that NGAL is a stron…”
ResultInfluentialNisula, S., Yang, R., Kaukonen, K., Vaara, S. T., Kuitunen, A., Tenhunen, J. J., Pettilä, V., & Korhonen, A. (2014) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000000243 · Cited by 29
Filiopoulos, V., Biblaki, D., & Vlassopoulos, D. (2014) · Renal Failure · doi:10.3109/0886022x.2014.900429 · Cited by 28
Olguner, Ç. G., Koca, U., Altekin, E., Ergür, B. U., Duru, S., Girgin, A. P., Taşdöğen, A., Gündüz, K., Güzeldağ, S., Akkuş, M., et al. (2013) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2013.1034 · Cited by 28
Clinical significance of NGAL and KIM-1 for acute kidney injury in patients with scrub typhus
Sun, I. O., Shin, S. H., Cho, A. Y., Yoon, H. J., Chang, M. Y., & Lee, K. Y. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175890 · Cited by 28
The origin of plasma neutrophil gelatinase-associated lipocalin in cardiac surgery
Passov, A., Petäjä, L. M., Pihlajoki, M., Salminen, U., Suojaranta, R., Vento, A. E., Andersson, S., Pettilä, V., Schramko, A. A., & Pesonen, E. (2019) · BMC Nephrology · doi:10.1186/s12882-019-1380-4 · Cited by 28
Sim, J., Yim, H., Choi, B., Lee, J. H., & Yoo, K. (2015) · Pediatric Research · doi:10.1038/pr.2015.59 · Cited by 28
“96, sensitivity was 84%, and specificity was 94% for prediction of AKI using a cut-off value of 150 ng/ml (34).”
Graphene-based immunoassay for human lipocalin-2.
Vashist, S. K. (2014) · Analytical Biochemistry · doi:10.1016/j.ab.2013.10.022 · Cited by 26
The promise of biomarkers for personalized renal cancer care
Devarajan, P. (2010) · Kidney International · doi:10.1038/ki.2010.26 · Cited by 26
Self-citationBuelow, M., Dall, A. T., Regner, K. R., Weinberg, C. R., Bartz, P. J., Sowinski, J., Rudd, N., Katzmark, L., Tweddell, J. S., & Earing, M. G. (2012) · Congenital Heart Disease · doi:10.1111/j.1747-0803.2012.00662.x · Cited by 25
Moffett, B. S., Goldstein, S. L., Adusei, M., Kuzin, J. K., Mohan, P., & Mott, A. R. (2011) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0b013e31820ac40a · Cited by 25
“Neonates (n 62) Norwood/Damus-Kaye-Stansel 29 (47) Blalock-Taussig shunt 8 (13) Arterial switch 4 (6) Total anomalous pulmonary venous return repair 4 (6) Aortic arch repair/reconstruction 3 (5) Coarctation repair 3 (5) Infants (n 195) Bidirectional Glenn 56 (29) Ventricular septal defect repair 27 (14) Complete atrio…”
BackgroundZou, Z., Chen, B., Tang, F., Li, X., & Xiao, D. (2023) · Frontiers in Pediatrics · doi:10.3389/fped.2023.1147033 · Cited by 26
Metadata
- Authors
- Dent, C. L., Ma, Q., Dastrala, S., Bennett, M., Mitsnefes, M. M., Barasch, J., & Devarajan, P.
- Affiliations
- Cincinnati Children's Hospital Medical Center (US)
- Columbia University (US)
- Corresponding author
- Devarajan, Prasad
- Venue
- Critical Care
- Published
- 2007-12-10
- Volume
- 11
- Issue
- 6
- Pages
- R127-R127
- ISSN
- 1364-8535 (ISSN-L)
- PMC
- PMC2246223
- OpenAlex
- W2035397803
- Cited by
- 483
- References
- 33
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 7 · 2023: 13 · 2022: 11 · 2021: 18 · 2020: 8 · 2019: 15 · 2018: 18 · 2017: 20 · 2016: 36 · 2015: 46 · 2014: 43 · 2013: 47 · 2012: 49
- FWCI
- 22.86
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/2.0/ (tdm)
- creativecommons.org/licenses/by/2.0/ (vor)
- Locations
- Critical Care (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- American Heart Association
- Cincinnati Children's Hospital Medical Center
- National Institutes of Health (DK52612)
- National Institute of Diabetes and Digestive and Kidney Diseases (R21DK070163, P50DK052612, R01DK053289)
- Topics
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Health Sciences › Medicine › Surgery › Cardiac and Coronary Surgery Techniques
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Keywords
- neutrophil gelatinase-associated lipocalin, acute kidney injury, pediatric cardiac surgery, cardiopulmonary bypass, point-of-care biomarkers, early prediction of AKI, serum creatinine, postoperative morbidity and mortality, length of hospital stay, renal function monitoring, pediatric congenital heart disease, postoperative renal complications, biomarker validation
- MeSH terms
- Lipocalin-2, Acute-Phase Proteins, Child, Child, Preschool, Cross-Sectional Studies, Female, Cardiac Surgical Procedures, Humans, Male, Morbidity, Mortality, Pilot Projects, Predictive Value of Tests, Prospective Studies, Proto-Oncogene Proteins, Cohort Studies, Biomarkers, Point-of-Care Systems, Lipocalins, Acute Kidney Injury
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.